Logan Steele
Metformin is the most commonly prescribed medication for treating diabetes. It is known to have some side effects, including vitamin B12 deficiency, which can cause muscle weakness and fatigue. Studies have also shown that metformin can induce muscle atrophy and negatively affect muscle response to resistance training. However, other studies suggest that metformin could help promote healthy muscle ageing and prevent age-related muscle atrophy. Therefore, this paragraph will explore the relationship between metformin and muscle mass, examining the potential benefits and drawbacks of the drug's effects on skeletal muscle.
| Characteristics | Values |
|---|---|
| Loss of muscle mass | Long-term metformin administration is associated with muscle atrophy, a severe condition that involves a remarkable loss of muscle mass and quality. |
| Loss of muscle mass in patients with type 2 diabetes | Patients with type 2 diabetes experience a loss of muscle mass and quality. |
| Loss of muscle mass in older men with type 2 diabetes | Older men with type 2 diabetes who took metformin had significantly lower leg lean mass and appendicular skeletal muscle mass compared to controls. |
| Vitamin B12 deficiency | Taking metformin for a long time can cause vitamin B12 deficiency, leading to symptoms such as tiredness, breathlessness, and feeling faint. |
| Muscle weakness | Metformin can cause muscle weakness. |
| Side effects | Metformin can cause side effects such as loss of appetite, a metallic taste in the mouth, mouth ulcers, problems with vision, and skin discolouration. |
| Muscle response to resistance training | A study found that metformin negatively affected the hypertrophic response to resistance training in healthy older individuals. |
| Skeletal muscle mitochondrial H2O2 emission and production | A short-term clinical trial found that metformin increased skeletal muscle H2O2 emission and production in healthy older adults without altering skeletal muscle maximal mitochondrial respiration. |
Explore related products
What You'll Learn
- Metformin is the most widely prescribed anti-diabetic drug for patients with type 2 diabetes
- Long-term metformin administration is associated with muscle atrophy
- Metformin negatively affects the hypertrophic response to resistance training in healthy older individuals
- Metformin causes vitamin B12 deficiency, leading to muscle weakness
- Metformin influences mitochondrial-free radical and satellite cell dynamics
Metformin is the most widely prescribed anti-diabetic drug for patients with type 2 diabetes
Metformin is typically taken two times a day and can be taken with food to reduce feelings of sickness as a side effect. It is important to note that metformin can cause vitamin B12 deficiency, especially with long-term use, which can lead to symptoms such as fatigue, breathlessness, and faintness. Other common side effects include a metallic taste in the mouth, loss of appetite, and diarrhoea.
While metformin is a valuable medication for managing type 2 diabetes, it is crucial to be aware of potential side effects and monitor vitamin B12 levels to ensure any deficiencies are addressed with supplements if needed. Additionally, patients taking metformin should be cautious about concurrent use with certain other medications, as this can enhance the hypoglycaemic effect of metformin and potentially lead to low blood sugar (hypoglycaemia).
It is always important for individuals with diabetes to follow a specially planned diet and exercise regimen, even when taking medications like metformin. The amount of medication must be balanced with the type and amount of food consumed, as well as physical activity levels. Any changes in diet or exercise routines should be accompanied by blood sugar testing to ensure levels do not drop too low.
Chemotherapy's Impact: Muscle Damage and Recovery
You may want to see also
Explore related products
Long-term metformin administration is associated with muscle atrophy
Metformin is the most commonly prescribed medication to treat diabetes, specifically type 2 diabetes. It is an AMPK agonist that helps to decrease hepatic glucose production and intestinal absorption of glucose, improving insulin sensitivity. However, while metformin is often beneficial for diabetic patients, long-term administration of the drug has been associated with muscle atrophy and vitamin B12 deficiency.
Muscle atrophy, or skeletal muscle atrophy, is a severe condition characterised by a decrease in muscle fibre size and protein content. It occurs when protein degradation rates exceed the rate of protein synthesis. Myostatin, a key regulator of skeletal muscle growth, plays a central role in the development and maintenance of skeletal muscle by acting as a negative regulator of muscle mass.
Several studies have found that metformin induces muscle atrophy by upregulating myostatin expression and triggering the phosphorylation of AMPK. One study found that metformin-treated patients experienced a decrease in lean body and thigh muscle mass compared to the placebo group, indicating that metformin negatively affects the hypertrophic response to resistance training. Another study found that patients with type 2 diabetes experienced a loss of muscle mass and quality, with insulin resistance and high blood glucose levels accelerating this condition.
However, it is important to note that the molecular mechanism of metformin in muscle is not yet fully understood, and further research is needed to elucidate its effects on skeletal muscle. While metformin may contribute to muscle atrophy, it is also speculated to have potential benefits in preventing or counteracting muscle atrophy caused by statins and age-related muscle loss.
Cold Symptoms: Muscle Aches and Pains Explained
You may want to see also
Explore related products
Metformin negatively affects the hypertrophic response to resistance training in healthy older individuals
Metformin is the most widely prescribed anti-diabetic drug for patients with type 2 diabetes. It is also among the top 10 most prescribed drugs in the United States. The drug is known to cause vitamin B12 deficiency, which can lead to muscle weakness and tiredness.
Several studies have been conducted to determine the effects of metformin on muscle mass, particularly in older adults. One such study is the MASTERS trial, which investigated the effects of metformin on muscle hypertrophy in response to progressive resistance exercise training (PRT) in older adults. The results of this trial showed that the placebo group gained more lean body mass and thigh muscle mass than the metformin-treated group. CT scans further revealed that the placebo group had greater increases in thigh muscle area and density.
Another study by Malin et al. (2012) found that when adults with prediabetes underwent concurrent aerobic and resistance training, metformin appeared to blunt the exercise-induced gains in lean mass. Similarly, Lee et al. (2011) observed that in the absence of resistance training, metformin delayed lean mass loss in men with type 2 diabetes.
The mechanism by which metformin induces muscle atrophy is through the transcriptional regulation of myostatin, a key molecule that regulates muscle volume. Myostatin expression is increased in various disease states, including type 2 diabetes, and its levels are further elevated by insulin resistance and high blood glucose levels. Metformin administration improves diabetes by reducing hepatic glucose production and intestinal glucose absorption, but it also has the side effect of increasing myostatin expression, which leads to muscle atrophy.
In summary, the available evidence suggests that metformin negatively affects the hypertrophic response to resistance training in healthy older individuals. While metformin may have benefits in delaying lean mass loss in the absence of exercise, it appears to blunt the gains typically achieved through resistance training. This may be due to its inhibitory effect on mTORC1, leading to decreased muscle protein synthesis or increased autophagy.
Muscle Spasms: Uncovering the Underlying Diseases and Disorders
You may want to see also
Explore related products
Metformin causes vitamin B12 deficiency, leading to muscle weakness
Metformin is the most widely prescribed anti-diabetic drug for patients with type 2 diabetes. It is also used to treat other conditions associated with insulin resistance, such as metabolic syndrome, nonalcoholic fatty liver disease, and polycystic ovary syndrome.
Metformin use has been linked to vitamin B12 deficiency, with several studies reporting an association between long-term metformin therapy and low vitamin B12 levels. This is due to metformin blocking the absorption of vitamin B12, although the exact mechanism is not yet fully understood. It is believed that metformin interferes with the calcium-dependent binding of the intrinsic factor vitamin B12 complex to the cubam receptor in the terminal ileum, impairing calcium availability and thus reducing the uptake of the B12-intrinsic factor complex by the ileal cell surface.
Vitamin B12 deficiency can lead to a range of clinical symptoms, including muscle weakness, a sore tongue, mouth ulcers, vision problems, and pale or yellow skin. It can also cause a delay in the maturation of red blood cells, leading to megaloblastic anemia, and is associated with peripheral neuropathy, a condition that causes weakness, numbness, and pain due to damage to the peripheral nerves outside the brain and spinal cord.
If you are taking metformin and experience any of these symptoms, it is important to consult your doctor or call 111. They may check your vitamin B12 serum levels and prescribe vitamin B12 supplements if necessary.
Thyroid Dysfunction: The Link to Muscle Cramps
You may want to see also
Explore related products
Metformin influences mitochondrial-free radical and satellite cell dynamics
Metformin is a drug commonly prescribed to treat type 2 diabetes, reducing glycaemia and body weight. However, the mechanisms of action are still not fully understood. Recent studies have identified the gastrointestinal tract as an important site of action. Metformin influences mitochondrial-free radical and satellite cell dynamics by inhibiting mitochondrial function and increasing glucose uptake, glycolysis, and GDF-15 release from intestinal cells. This increase in glucose uptake is likely a result of metformin's ability to inhibit mitochondrial respiration.
Several studies have investigated the effects of metformin on intestinal cell physiology using intestinal organoids and bulk RNA-sequencing analysis. These studies have identified changes in hexose metabolism pathways, particularly glycolytic genes. Specifically, metformin increased the expression of Slc2a1 (GLUT1) and decreased the expression of Slc2a2 (GLUT2) and Slc5a1 (SGLT1). These changes in gene expression resulted in increased GLUT-dependent glucose uptake and a higher glycolytic rate.
Additionally, metformin has been shown to inhibit mitochondrial adaptations to aerobic exercise training in older adults. In a double-blind study, participants who underwent 12 weeks of aerobic exercise training (AET) experienced an increase in whole-body insulin sensitivity and VO2max. However, those taking metformin during the study did not show the same increase in whole-body insulin sensitivity or VO2max. Metformin also abrogated the exercise-mediated increase in skeletal muscle mitochondrial respiration.
While metformin can be beneficial for managing type 2 diabetes and improving insulin sensitivity, it is important to consider its potential side effects. Long-term use of metformin has been associated with muscle atrophy and a negative impact on muscle mass and strength. This may be due to its influence on myostatin expression, a key molecule that regulates muscle volume. Additionally, metformin can cause vitamin B12 deficiency, leading to symptoms such as fatigue, breathlessness, and muscle weakness. Therefore, it is crucial for individuals taking metformin to be aware of these potential side effects and consult their doctor or pharmacist if any adverse reactions occur.
Muscle Deterioration in Dogs: What Are the Causes?
You may want to see also
Frequently asked questions
Metformin is the most commonly prescribed medication to treat diabetes. It is an AMPK agonist that is administered to patients with type 2 diabetes to decrease hepatic glucose production and intestinal absorption of glucose.
Long-term metformin administration is associated with side effects such as muscle atrophy or skeletal muscle atrophy, a condition that involves a loss of muscle mass and quality. However, some studies suggest that metformin could have off-target effects that might help promote healthy muscle aging.
Like all medicines, metformin can cause side effects, although not everyone gets them. Some common side effects of metformin are loss of appetite, a metallic taste in the mouth, vitamin B12 deficiency, and muscle weakness.
